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The twin epidemics of HIV and tuberculosis (TB) have resulted 
in a surge in HIV-TB co-infection. In 2015, 1.2 million new cases 
of TB were diagnosed in patients living with HIV worldwide, 
with 400 000 deaths.[1,2] The burden of this epidemic is most 
prominent in the developing world, where resources for diagnosis 
and treatment are limited, which further hampers containment of 
the epidemic.[1-3] Typically, 10 - 15% of patients with TB develop 
the infection in sites other than the lungs, i.e. extrapulmonary TB 
(EPTB).[4-8] Among people living with HIV, EPTB can occur in 
>50% of cases.[4,5,7-9] The diagnosis of TB is usually made by sputum 
smear, culture, biopsy, or molecular detection methods. Diagnosing 
EPTB in patients with HIV, however, is challenging. In the absence 
of active pulmonary TB and in the presence of HIV, sputum smears 
or cultures to diagnose EPTB are unreliable and can be positive 
in as few as 3% of patients.[6,10,11] Likewise, chest radiographs are 
not helpful in EPTB and are negative in up to 27% of cases.[12] In 
resource-limited settings, the diagnosis of EPTB is often made on 
the basis of clinical findings alone, which can lead to a delay in 
diagnosis and increased mortality. While molecular methods of TB 
detection are improving and can offer rapid turnaround of results, 
they are not yet widely available.[13-15]
Recently ultrasound, particularly point-of-care ultrasound (POCUS), 
has emerged as a useful modality to diagnose advanced EPTB.[16] 
Its use has increased in resource-limited settings, as it is a cheap, 
portable and repeatable diagnostic modality that offers rapid data 
return.[17-19] Typical EPTB ultrasound findings are free abdominal 
fluid, pericardial effusion, periaortic lymph nodes and splenic 
microabscesses.[20-26] It is known that both HIV and TB can cause 
free intra-abdominal or pericardial fluid and lymphadenopathy 
independently, but splenic microabscesses are believed to be very 
specific for EPTB.[27,28]
The focused assessment with sonography for HIV-associated 
TB (FASH) protocol was developed to enable treating doctors to 
identify EPTB rapidly in patients with HIV in endemic areas.[16] 
The developers of this protocol argued that the presence of positive 
FASH findings in the right setting indicates disseminated EPTB that 
should prompt treatment without waiting for additional diagnostic 
data. [16,21] However, much of the published research supporting the 
FASH protocol is based on ultrasound findings or clinical progression 
alone rather than culture data.[10,21,27-30] There is a paucity of systematic 
data on the frequency and specificity of splenic microabscesses 
seen on ultrasound in patients with culture-proven EPTB, and 
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Background. In 2015, 1.2 million new cases of tuberculosis (TB) were diagnosed in patients with HIV. Diagnostic limitations and 
resource shortages in endemic areas can delay diagnosis and treatment, particularly with extrapulmonary TB (EPTB). Research suggests 
that ultrasound can identify splenic microabscesses caused by EPTB, but data are limited on the frequency of this finding in patients 
with culture-proven EPTB.
Objectives. To estimate the frequency of splenic EPTB microabscesses detected with ultrasound in patients with HIV and TB co-infection.
Methods. Studies published in six major databases as of November 2017 were systematically reviewed based on the PRISMA guidelines. 
Cohen’s kappa test was used to determine inter-rater agreement. Articles included for data abstraction passed the Quality Assessment 
of Diagnostic Accuracy Studies (QUADAS-2) evaluation. Freeman-Tukey transformation was used to calculate weighted proportions. 
Heterogeneity was evaluated by Forest plot and I2 calculation.
Results. After abstract screening, article review and QUADAS-2 evaluation, five studies were selected for data extraction. A total of 
774 patients in these studies were infected with HIV. Splenic lesions were seen with ultrasound in 21.0% of patients with HIV (95% 
confidence interval (CI) 10.6 - 33.8). TB diagnosed by culture, biopsy, smear, or molecular methods was found to be the cause of 88.3% 
(95% CI 72.3 - 97.9) of splenic microabscesses seen on ultrasound in patients with HIV.
Conclusions. Ultrasound evaluation of the spleen in patients with HIV and symptoms suggestive of TB in endemic regions is a viable 
diagnostic adjunct. Ultrasound detection of splenic microabscesses in HIV patients is probably sufficient indication to initiate TB 
treatment prior to obtaining culture data. Strong conclusions cannot be drawn owing to the high heterogeneity of this small number of 
studies.
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other organisms aside from the tubercle 
bacterium can cause disseminated splenic 
abscess development.[31,32]
Objectives
The objective of this systematic review was 
to determine the sonographic frequency of 
TB splenic microabscesses in patients with 
HIV and confirmed TB co-infection.
Methods
Search strategy, selection criteria 
and assessment of quality
A systematic review was conducted of all 
published literature in PubMed, Embase, 
Web of Science, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), 
Latin American and Caribbean Health 
Sciences Literature (LILACS) and African 
Index Medicus (AIM) publications prior to 
28 November 2017. Updates were conducted 
in November 2016 and November 2017. 
Keywords and search terms were generated 
for TB and ultrasound with the help of 
a research librarian (Appendix 1). Search 
strategy and methods were based on the 
PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-analyses) 
checklist.[33] The resulting database of 
articles was further refined with addition 
of HIV keywords. The inclusion criteria 
were not limited on the basis of language, 
geographical region, year, or study setting 
income stratification. Two independent 
reviewers screened abstracts for exclusion 
criteria, which were as follows: non-human 
studies, case reports, case series with three or 
fewer subjects, or studies relying on invasive 
ultrasound modalities (trans-oesophageal or 
endoscopic) alone as the basis for imaging 
evaluation. A third reviewer was used to gain 
consensus when conflict arose. Abstracts 
were included if all study participants had 
known HIV status and underwent non-
invasive abdominal ultrasonography, and 
TB infection status was determined on the 
basis of confirmatory data such as culture, 
biopsy, smear, or molecular detection 
methods. Articles included for full review 
were assessed for quality with the Revised 
Quality Assessment of Diagnostic Accuracy 
Studies (QUADAS-2) tool.[34] With this tool, 
articles meeting the inclusion criteria were 
screened for possible selection, performance 
and reporting bias. Articles that passed this 
screening step were included for final data 
extraction and statistical analysis.
Data abstraction
Data extraction was standardised to include 
geographical location of the study, study 
design, characteristics of the population 
such as HIV and TB status, and method 
of determining TB status. Data regarding 
presence or absence of splenic lesions on 
ultrasound found with the use of either 
low-frequency or high-frequency ultrasound 
transducers were also abstracted. Authors 
of the selected studies were contacted as 
needed to clarify any missing data such as 
HIV status or ultrasound transducer used 
for evaluation of splenic lesions.
Statistical analysis
During screening, inter-rater agreement 
was assessed using Cohen’s kappa test. Data 
from studies that passed the QUADAS-2 
evalua tion were pooled to calculate three 
parameters: (i) the rate of TB splenic 
microabscesses in patients with HIV-TB 
co-infection; (ii) the rate of splenic lesions 
in all patients with HIV; and (iii) the rate 
of TB microabscesses out of all splenic 
lesions in patients with HIV. The Freeman-
Tukey transformation (arcsine square root 
transformation) was used to calculate the 
weighted summary proportion for each of 
these parameters under the fixed and ran-
dom-effects model.[35,36] Heterogeneity  was 
assessed by graphic examination of Forest 
plots and by calculating I2 and Cochrane’s 
Q.[37] Publication bias was assessed by Egger’s 
regression intercept. [38] We used MedCalc 
Statistical Software version 14.8.1 (MedCalc 
Software,  Belgium; http://www.medcalc.org, 
2014) and Comprehensive Meta-Analysis 
version 2.2.064 (Biostat, USA). A two-tailed 
p-value <0.05 was considered statistically 
significant.
Role of the funding source
There was no funding source for this study. 
The corresponding author had full access to 
the data in the study and final responsibility 
for the decision to submit for publi cation.
Results
Search and screening results are listed in 
Fig.  1. The initial search returned 5 545 
unique articles for TB and ultrasound. The 
addition of HIV keywords a priori to this 
database further refined the results to 993 
abstracts. Two reviewers screened these 
abstracts, returning 54 articles pertaining 
to splenic lesions on ultrasound in patients 
with HIV and TB co-infection. Reviewers 
had a kappa coefficient of 0.9 (95% 
confidence interval (CI) 0.7 - 1) for inter-
rater agreement. After the QUADAS-2 tool 
was applied, five studies were selected for 
data extraction. The other 49 articles were 
excluded for the following reasons: 7 were 
case control studies; 22 based the diagnosis 
of EPTB on clinical or empirical parameters 
rather than strictly culture, biopsy, smear, 
or molecular data, or there was insufficient 
information on methods of diagnosing TB; 
5 studies had mixed use of either computed 
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Fig. 1. Systematic review search and screening results. (CINAHL = Cumulative Index to Nursing and 
Allied Health Literature; LILACS = Latin American and Caribbean Health Sciences Literature; AIM = 
African Index Medicus; TB = tuberculosis; QUADAS-2 = Quality Assessment of Diagnostic Accuracy 
Studies; dx = diagnosis; CT = computed tomography; US = ultrasound.)
572       August 2019, Vol. 109, No. 8
RESEARCH
tomography or ultrasound as the imaging 
modalities, or did not comment on splenic 
ultrasound findings; 2 were either reviews or 
meta-analyses; 6 evaluated procedures; and 
7 were only available in limited abstract or 
poster presentation form. Table 1 lists the five 
selected articles and the key characteristics 
of each.
Pooled results
The five studies included a total of 840 
patients who had an abdominal ultrasound 
scan. Of these patients, 774 had HIV 
infection. TB co-infection was confirmed 
in 337 of patients with HIV. Ultrasound 
detected hypoechoic splenic lesions in 151 
of the 840 patients. Splenic microabscesses 
found on ultrasound were confirmed to be 
EPTB in 137 of these patients.
Forest plots, I2 and Cochrane’s Q-tests 
were used to evaluate heterogeneity of these 
studies. The Forest plots with associated 
I2 and Cochrane’s Q-values of pooled data 
from the five selected studies are listed in 
Figs 2 - 4. There was high heterogeneity 
among the studies, so weighted summary 
proportion was calculated using Freeman-
Tukey transformation (arcsine square root 
transformation) under a random-effects 
model.
The proportion of splenic microabscesses 
in patients with HIV and TB co-infection 
is presented in Fig. 2. There was high 
heterogeneity, with Cochrane’s Q at 66.9 
(p<0.0001) and I2 94.0% (95% CI 88.9 - 96.8), 
so a random-effects model was used. Of 
the 337 patients with HIV-TB co-infection, 
62.5% had splenic microabscesses with 
culture-proven TB (95% CI 38.1 - 83.9). 
Egger’s regression intercept to evaluate 
publication bias was 2.62 (95% CI –0.3 - 5.5; 
p=0.064), indicating that no publication bias 
was found.
The proportion of splenic lesions on 
ultrasound in all patients with HIV is shown 
in Fig. 3. Cochrane’s Q was 63.2 (p<0.0001) 
and I2 was 93.7% (95% CI 88.1 - 96.6), 
indicating high heterogeneity, so a random-
effects model was used. Of 774 patients with 
HIV, splenic lesions were seen in 21.0% (95% 
CI 10.6 - 33.8). Egger’s regression to assess 
publication bias was –7.3 (95% CI –30.7 - 
16.2; p=0.4), indicating that no publication 
bias was found.
The proportion of TB microabscesses out 
of all splenic lesions in patients with HIV 
is shown in Fig. 4. Cochrane’s Q was 24.6 
(p<0.0001) and I2 was 83.8% (95% CI 63.3 - 
92.8), indicating high heterogeneity, so a 
random-effects model was used. Of patients 
with HIV and splenic microabscesses on 
ultrasound, 88.3% had TB diagnosed by 
culture, biopsy, smear or molecular methods 
(95% CI 72.3 - 97.9). Egger’s regression inter-
cept was 4.6 (95% CI –1.7 - 11.0; p=0.10), 
indicating that no publication bias was 
found.
Results of individual studies
Murray et al.[39] (1995) compared rates of 
splenic microabscess detection between a 
3.5 MHz sector transducer and a 5 MHz 
linear transducer in patients with HIV. This 
study was done in the USA on a prospective 
convenience sample of patients with known 
HIV status presenting for investigation 
of abdominal pain between June 1993 
and October 1994. Of 102 patients who 
underwent abdominal ultrasonography, 13 
were found to have splenic lesions. Use 
of a low-frequency transducer was able to 
identify splenic lesions in 3 patients, while 
an additional 10 patients were recategorised 
as having lesions after evaluation with a 
high-frequency linear probe. Seven of these 
patients had a TB diagnosis based on culture, 
biopsy or autopsy, 3 had Mycobacterium 
avium-intracellulare infection, 1 had Kaposi’s 
sarcoma, and 1 had Pneumocystis carinii 
infection. The remaining patient was 
presumed to have disseminated candidiasis 
based on ultrasound appearance of the 
splenic lesion and improvement with anti-
fungal medication.
Porcel-Martin et al.[40] (1998) published 
a retrospective review of patients with HIV 
who underwent abdominal ultrasonography 
between January 1987 and December 1995 at 
one hospital in Spain. The objective of their 
research was to describe splenic ultrasound 
findings in this patient population. They 
used 3.5 MHz sector and linear transducers 
to evaluate the spleen. Of 22 patients found 
to have focal splenic lesions, 19 had culture- 
or biopsy-proven EPTB. One patient had a 
splenic infarct from Staphylococcus aureus 
bacterial endocarditis, and in 2 patients the 
final diagnosis was unknown because of lack 
of follow-up.
Mendez et al.[41] (1995) evaluated 77 
patients in Argentina who presented with 
known HIV and fever. This was a prospective 
cohort study to evaluate the usefulness of 
ultrasound in detecting abdominal TB in 
HIV-positive patients. They used 3.5 MHz 
sector and linear transducers. Of 74 patients 
with culture- or biopsy-proven TB, 29 had 
splenic microabscesses with confirmed TB.
More recently, in 2011, Patel et al.[42] 
published a prospective cohort study of 
ultrasound findings in patients with sus-
pected EPTB admitted to a district-level 
hospital in South Africa from August 2004 
to October 2004. Ultrasound of the spleen 
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was performed using a 3.5 MHz curvilinear transducer and a 
7.5  MHz linear transducer. Of 267 patients who met the inclusion 
criteria and had adequate data to confirm a diagnosis of TB, 170 
had TB confirmed by either culture or smear. Of the 267 patients in 
this study, 66 were either HIV-negative or of unknown HIV status, 
while the remaining 201 were HIV-positive. Of 63 patients found to 
have splenic microabscesses, the majority (n=62) were HIV-positive 
with a final diagnosis of EPTB. The single HIV-negative patient in 
this group with splenic lesions did not have TB. The authors did not 
specify what the final diagnosis was in this case.
Dominguez-Castellano et al.[43] (1998) conducted a prospective 
cohort study of patients admitted to one hospital in Spain from April 
1994 to January 1997. The objective of this study was to evaluate 
abdominal ultrasound as a diagnostic tool to identify EPTB in 
patients with HIV. They used a 3.75 MHz curvilinear transducer 
to scan for splenic lesions, abdominal lymphadenopathy or liver 
lesions. Of 116 patients with HIV and fever evaluated with abdominal 
ultrasound, 35 had a combination of abdominal ultrasound findings 
and 25 of these had a final diagnosis of EPTB; 24 patients had splenic 
microabscesses on ultrasound. Of these microabscesses, 20 were 
biopsy- or culture-proven TB, while 1 was caused by toxoplasmosis 
and 1 by M. avium-intracellulare. In 2 cases there was no definitive 
diagnosis. The authors noted that one patient with ultrasound 
findings had a presumptive diagnosis of TB based on clinical 
improvement, but they did not state what specific ultrasound finding 
this case was associated with.
Discussion
Five studies that used abdominal ultrasound in the diagnostic 
algorithm when evaluating for EPTB were reviewed. Each of these 
studies were selected because the diagnosis of TB was confirmed by 
culture, biopsy, smear, or molecular methods. HIV status was known 
in a majority of patients included in this review (794/840 patients, 
774 HIV-positive and 20 HIV-negative). Splenic microabscesses 
were present in 21.0% of all patients with HIV infection. Of patients 
with HIV and TB co-infection, 62.5% had splenic microabscesses. 
Furthermore, in patients with HIV, these splenic microabscesses 
were caused by culture-proven EPTB in 88.3% of cases. The above 
data indicate that splenic microabscesses were not a frequent finding, 
but when present were usually caused by EPTB. Therefore, in HIV-
positive patients with unknown TB status but symptoms suggestive 
of TB, splenic microabscesses detected on ultrasound are probably 
caused by EPTB, and this possibility may be sufficient indication to 
initiate TB treatment while awaiting culture data, particularly in a 
setting with a high prevalence of HIV and TB and limited resources.
A strength of this review is that we focused on diagnostic 
modalities likely to be available to the front-line provider. The review 
focused primarily on transabdominal ultrasound and excluded 
invasive ultrasound modalities, as these do not easily translate to 
POCUS applications. Invasive modalities would probably not be 
available to the front-line clinician practising in an HIV-TB-endemic 
area with limited resources. It was with this subset of clinicians 
in mind that we chose to focus on splenic microabscesses as an 
ultrasound finding associated with EPTB.
There are other ultrasound findings commonly associated with 
EPTB that we could have investigated, but these findings present 
their own challenges. Abdominal lymphadenopathy is a common 
finding with EPTB in patients with HIV; however, abdominal 
lymph nodes can be difficult to identify, even for experienced 
sonographers. [31,44] Ascities is associated with TB but also with a 
wide variety of other conditions.[45] We therefore chose to focus on 
splenic microabscesses, as they are relatively easy for a clinician with 
limited ultrasound experience to identify.[46,47] Given that POCUS 
is cheap and portable, and provides data rapidly to the treating 
clinician, ultrasound evaluation of the spleen in patients with HIV 
and symptoms suggestive of TB is a beneficial addition to diagnostic 
and treatment algorithms in resource-limited settings.
During the screening process, we found 22 articles that discussed 
the presence of splenic microabscesses in patients with HIV and TB 
co-infection.[12,21,24,27,28,30,48-63] These articles were excluded because 
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Fig. 2. Forest plot of selected articles: rate of TB splenic microabscesses in 
patients with HIV-TB co-infection. (TB = tuberculosis; CI = confidence 
interval.)
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TB was diagnosed either entirely or partially on the basis of clinical 
or ultrasound features rather than strictly by culture, biopsy, or 
molecular methods. Smear-negative TB and EPTB can be difficult 
to diagnose, particularly in patients with HIV.[6,10-12] Criteria for 
diagnosis are often based on clinical signs or symptoms as well as 
improvement in symptoms after initiation of TB treatment, because 
EPTB or smear-negative TB is so difficult to diagnose.[10,29] The 
excluded articles followed World Health Organization guidelines 
for diagnosing EPTB, and were well structured; however, we were 
looking for research that indicated a definitive culture- or biopsy-
proven diagnosis of TB, as patients with HIV are also susceptible to 
other opportunistic infections or malignancy that can present in a 
similar way. Looking only for articles with a definitive TB diagnosis 
introduces potential bias into our screening process. However, taken 
together the excluded articles indicate that splenic microabscesses 
appear to be a very specific finding associated with EPTB in HIV-
positive patients, particularly in endemic areas. Our findings add 
support to this observation.
Study limitations
As with any systematic review, publication bias is a problem. Using 
the methods we have described, we searched six major databases for 
published articles. However, published articles do not encompass 
the entire breadth of research on this topic, and we did not include 
unpublished research that might have been relevant. Additionally, 
through the screening and selection process we identified very few 
articles that used culture or biopsy data as the basis of definitive 
EPTB diagnosis. We attempted to evaluate for potential publication 
bias using Egger’s regression intercept, but this is of limited usefulness 
with such a small number of articles.[38] Publication bias as assessed 
with our method was low; however, considering the research and 
publication barriers faced by clinicians and researchers in low- and 
middle-income countries, it is possible that there are unpublished 
data on this topic.[64-66] Our assessment of publication bias must 
therefore be interpreted with these limitations in mind.
We noted high heterogeneity in the five selected articles. Differences 
in study objectives, changes in geographical and temporal distribution 
of TB and HIV in relation to the growing HIV epidemic, and some 
of the diagnostic methods used contribute to this heterogeneity. We 
adjusted for this problem by using a random-effects model to calculate 
probability. Even so, the estimates presented are not robust owing to 
the limited number of heterogeneous studies that passed the screening 
process, and strong conclusions cannot be drawn based on these data.
One of the differences noted between articles was ultrasound 
transducer selection. Four of the five articles reported using two 
types of transducers to evaluate the spleen, either a sector or 
curvilinear transducer and a linear transducer. All five used a 
low-frequency transducer of 3.5 or 3.75 MHz, which is a standard 
low-frequency transducer for abdominal ultrasound scans. A linear 
transducer typically offers higher-frequency settings and therefore 
better resolution. Two investigators indicated that they used an 
additional high-frequency linear transducer of either 5 or 7.5 MHz for 
splenic tissue.[39,42] Two other studies indicated that a high-frequency 
linear transducer was used, but did not indicate the frequency.[40,41] 
Higher-frequency ultrasound transducers are not routinely used for 
abdominal examinations, but the rationale behind their use in this 
context is that they can show more detailed parenchymal images and 
may be more sensitive for detecting splenic microabscesses.
Murray et al.[39] identified splenic lesions with the 3.5 MHz 
frequency transducer in 3 out of 13 patients, but found 4 additi onal 
patients when the 7.5 MHz transducer was used. Three other studies 
used a high-frequency linear transducer in addition to the standard 
3.5 MHz transducer, but did not specify whether additional patients 
were identified by using the high-frequency trans ducer. [40-42] One of 
the studies only used a low-frequency transducer.[43] The differences 
in transducer frequency selection among these studies could have the 
potential to falsely underestimate the frequency of splenic lesions. 
However, future research evaluating POCUS for this approach 
should include a low- and high-frequency transducer approach to 
potentially increase the sensitivity of splenic microabscess detection.
We did not exclude articles on the basis of geographical region or 
time in this search. Both high- and low- to middle-income countries 
are represented and an almost 20-year span is covered, starting in 
the mid-1990s. The shifting demographics of the HIV epidemic 
are likely to have changed the applicability of these findings in 
high-income countries, where the incidences of HIV and TB are 
substantially lower than in low- or middle-income countries.
Conclusions
The twin epidemics of HIV and TB are fuelling a rise in cases of 
EPTB, particularly in the developing world. Ultrasound is a cheap 
and portable diagnostic tool that can offer a partial solution to the 
difficulty of diagnosing EPTB in a resource-limited setting. While this 
review focused on sonographic detection of splenic microabscesses, 
there are other ultrasound findings associated with EPTB in patients 
with HIV, such as pericardial effusion or periaortic lymph node 
enlargement. While many of these findings have not been validated, 
additional meta-analysis of the current literature on the frequency 
of these ultrasound findings may help strengthen available data for 
diagnosing EPTB in at-risk patients using POCUS. In our review, 
we found that splenic microabscesses in patients with HIV are 
frequently caused by EPTB. This ultrasound finding in patients 
with HIV living in TB-endemic areas should prompt the clinician to 
initiate anti-TB treatment, prior to any confirmatory laboratory data. 
However, strong conclusions cannot be drawn because of the high 
heterogeneity of the limited number of studies that passed the search 
and screening process.
Declaration. None.
Acknowledgements. Thanks to Paul Bain, PhD, MLIS, reference and 
education librarian at Countway Library of Medicine at Harvard Medical 
School, for assistance in generating search terms for each database.
Author contributions. JMS and BH conceived the protocol. JMS did the 
literature search. JMS, BH and JW did the abstract screening and article 
review. JMS and BH did the quality assessment. JMS did the data extraction 
and contributed to the figures and tables. VN contributed to data analysis, 
created the figures and edited the manuscript. JMS prepared the first draft 
of the manuscript, and all authors were involved in data interpretation. All 
authors (JMS, JW, VN, DSB, TB, LN, EKK and BH) critically revised all 
drafts of the manuscript and approved the final version.
Funding. None.
Conflicts of interest. None.
1. World Health Organization. Global Tuberculosis Report 2016. Geneva: WHO, 2016. http://www.searo.
who.int/tb/documents/global-tuberculosis-report-2016/en/ (accessed 20 January 2017).
2. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: Global trends and 
interactions with the HIV epidemic. Arch Intern Med 2003;163(9):1009-1021. https://doi.org/10.1001/
archinte.163.9.1009
3. Perkins MD, Cunningham J. Facing the crisis: Improving the diagnosis of tuberculosis in the HIV era. 
J Infect Dis 2007;196(Suppl 1):S15-S27. https://doi.org/10.1086/518656
4. Ade S, Harries AD, Trebucq A, et al. National profile and treatment outcomes of patients with extra-
pulmonary tuberculosis in Benin. PloS One 2014;22;9(4):e95603. https://doi.org/10.1371/journal.
pone.0095603
5. Berg S, Schelling E, Hailu E, et al. Investigation of the high rates of extrapulmonary tuberculosis 
in Ethiopia reveals no single driving factor and minimal evidence for zoonotic transmission of 
Mycobacterium bovis infection. BMC Infect Dis 2015;15:112. https://doi.org/10.1186/s12879-015-
0846-7
575       August 2019, Vol. 109, No. 8
RESEARCH
6. Kwanjana IH, Harries AD, Hargreaves NJ, van Gorkom J, Ringdal T, Salaniponi FM. Sputum-smear 
examination in patients with extrapulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 
2000;94(4):395-398. https://doi.org/10.1016/s0035-9203(00)90117-2
7. Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European Union 
and European Economic Area, 2002 to 2011. Euro Surveill 2013;18(12)pii:20431. https://www.
eurosurveillance.org/content/10.2807/ese.18.12.20431-en (accessed 2 July 2019).
8. Rock RB, Sutherland WM, Baker C, Williams DN. Extrapulmonary tuberculosis among Somalis in 
Minnesota. Emerg Infect Dis 2006;12(9):1434-1436. https://doi.org/10.3201/eid1209.050295
9. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004;120(4):316-353.
10. Harries AD, Hargreaves NJ, Kwanjana JH, Salaniponi FM. The diagnosis of extrapulmonary 
tuberculosis in Malawi. Trop Doct 2003;33(1):7-11. https://doi.org/10.1177/004947550303300106
11. Harries AD, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-
negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World 
Health Organ 1998;76(6):651-662.
12. Heller T, Goblirsch S, Bahlas S, et al. Diagnostic value of FASH ultrasound and chest X-ray in HIV-
co-infected patients with abdominal tuberculosis. Int J Tuberc Lung Dis 2013;17(3):342-344. https://
doi.org/10.5588/ijtld.12.0679
13. Corstjens PL, Tjon Kon Fat EM, de Dood CJ, et al. Multi-center evaluation of a user-friendly lateral 
flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa. Clin 
Biochem 2016;49(1-2):22-31. https://doi.org/10.1016/j.clinbiochem.2015.08.013
14. World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid 
and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System: Policy 
Statement. Geneva: WHO, 2011. http://www.who.int/tb/publications/tb-amplificationtechnology-
statement/en/ (accessed 17 December 2016).
15. Steingart KR, Sohn H, Schiller I, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and 
rifampicin resistance in adults. Cochrane Database Syst Rev 2013, Issue 1. Art. No.: CD009593. https://
doi.org/10.1002/14651858.cd009593.pub2
16. Heller T, Wallrauch C, Goblirsch S, Brunetti E. Focused assessment with sonography for HIV-
associated tuberculosis (FASH): A short protocol and a pictorial review. Crit Ultrasound J 2012;4(1):21. 
https://doi.org/10.1186/2036-7902-4-21
17. Brindle HE, Allain TJ, Kampondeni S, et al. Utilization of ultrasound in medical inpatients in Malawi. 
Trans R Soc Trop Med Hyg 2013;107(7):405-410. https://doi.org/10.1093/trstmh/trt034
18. Groen RS, Leow JJ, Sadasivam V, Kushner AL. Review: Indications for ultrasound use in low- and 
middle-income countries. Trop Med Int Health 2011;16(12):1525-1535. https://doi.org/10.1111/
j.1365-3156.2011.02868.x
19. Van Hoving DJ, Lamprecht HH, Stander M, et al. Adequacy of the emergency point-of-care ultrasound 
core curriculum for the local burden of disease in South Africa. Emerg Med J 2013;30(4):312-315. 
https://doi.org/10.1136/emermed-2012-201358
20. Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without 
HIV infection. Tuber Lung Dis 1994;75(6):429-434. https://doi.org/10.1016/0962-8479(94)90116-3
21. Goblirsch S, Bahlas S, Ahmed M, Brunetti E, Wallrauch C, Heller T. Ultrasound findings in cases 
of extrapulmonary TB in patients with HIV infection in Jeddah, Saudi Arabia. Asian Pac J Trop Dis 
2014;4(1):14-17. https://doi.org/10.1016/s2222-1808(14)60306-6
22. Pereira JM, Madureira AJ, Vieira A, Ramos I. Abdominal tuberculosis: Imaging features. Eur J Radiol 
2005;55(2):173-180. https://doi.org/10.1016/j.ejrad.2005.04.015
23. Sculier D, Vannarith C, Pe R, et al. Performance of abdominal ultrasound for diagnosis of tuberculosis 
in HIV-infected persons living in Cambodia. J Acquir Immune Defic Syndr 2010;55(4):500-502. 
https://doi.org/10.1097/qai.0b013e3181e6a703
24. Sinkala E, Gray S, Zulu I, et al. Clinical and ultrasonographic features of abdominal tuberculosis in 
HIV positive adults in Zambia. BMC Infect Dis 2009;9:44. https://doi.org/10.1186/1471-2334-9-44
25. Brunetti EL, Brigada RL, Poletti FL, et al. Die Rolle der Abdomen-Sonographie in der 
klinischen Betreuung von Aids-Patienten. Ultraschall Med 2006;27(1):20-33. https://doi.
org/10.1055/s-2005-858649
26. Dos Santos RP, Scheid KL, Willers DMC, Goldani LZ. Comparative radiological features of 
disseminated disease due to Mycobacterium tuberculosis vs non-tuberculosis mycobacteria among 
AIDS patients in Brazil. BMC Infect Dis 2008;8:24. https://doi.org/10.1186/1471-2334-8-24
27. Giordani MT, Brunetti E, Binazzi R, et al. Extrapulmonary mycobacterial infections in a cohort of 
HIV-positive patients: Ultrasound experience from Vicenza, Italy. Infection 2013;41(2):409-414. 
https://doi.org/10.1007/s15010-012-0336-4
28. Heller T, Goblirsch S, Wallrauch C, Lessells R, Brunetti E. Abdominal tuberculosis: Sonographic 
diagnosis and treatment response in HIV-positive adults in rural South Africa. Int J Infect Dis 
2010;14(Suppl 3):e108-e112. https://doi.org/10.1016/j.ijid.2009.11.030
29. World Health Organization. Improving the Diagnosis and Treatment Among Adults and Adolescents: 
Recommendations for HIV-prevalent and Resource-constrained Settings. Geneva: WHO, 2007. http://
www.who.int/iris/handle/10665/69463 (accessed 7 December 2015).
30. Agarwal D, Narayan S, Chakravarty J, Sundar S. Ultrasonography for diagnosis of abdominal 
tuberculosis in HIV infected people. Indian J Med Res 2010;132:77-80.
31. Tarantino L, Giorgio A, de Stefano G, et al. [Diagnosis of disseminated mycobacterial infection in 
AIDS patients by US-guided fine needle aspiration biopsy of lymphnodes and spleen]. Infez Med 
2004;12(2):27-33. https://doi.org/10.1007/s00261-003-0035-9
32. Sutherland T, Temple F, Hennessy O, Lee WK. Abdomen’s forgotten organ: Sonography and CT of 
focal splenic lesions. J Med Imaging Radiat Oncol 2010;54(2):120-128. https://doi.org/10.1111/j.1754-
9485.2010.02149.x
33. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015;349:g7647. https://doi.
org/10.1136/bmj.g7647
34. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment 
of diagnostic accuracy studies. Ann Intern Med 2011;155(8):529-536. https://doi.org/10.7326/0003-
4819-155-8-201110180-00009
35. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 
1950;21(4):607-611. https://doi.org/10.1214/aoms/1177729756
36. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-188. https://
doi.org/10.1016/0197-2456(86)90046-2
37. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539-
1558. https://doi.org/10.1002/sim.1186
38. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical 
test. BMJ 1997;315(7109):629-634. https://doi.org/10.1136/bmj.315.7109.629
39. Murray JG, Patel MD, Lee S, Sandhu JS, Feldstein VA. Microabscesses of the liver and spleen in 
AIDS: Detection with 5-MHz sonography. Radiology 1995;197(3):723-727. https://doi.org/10.1148/
radiology.197.3.7480745
40. Porcel-Martin A, Rendon-Unceta P, Bascunana-Quirell A, et al. Focal splenic lesions in patients 
with AIDS: Sonographic findings. Abdom Imaging 1998;23(2):196-200. https://doi.org/10.1007/
s002619900322
41. Méndez N, di Lonardo M, Sawicki M, Gancedo E, Rasgido A, Fainboim H. La ultrasonografía 
abdominal como método diagnóstico orientador en tuberculosis y/o micobacteriosis en pacientes 
H.I.V. Rev Argent Radiol 1995;59(2):87-91.
42. Patel MN, Beningfield S, Burch V. Abdominal and pericardial ultrasound in suspected extrapulmonary 
or disseminated tuberculosis. S Afr Med J 2011;101(1):39-42. https://doi.org/10.7196/SAMJ.4201
43. Dominguez-Castellano A, Yanez P, Muniain MA, et al. [The usefulness of abdominal echography in 
the diagnosis of extrapulmonary tuberculosis in patients with HIV infection]. Enferm Infecc Microbiol 
Clin 1998;16(2):61-65.
44. Monill-Serra JM, Martinez-Noguera A, Montserrat E, Maideu J, Sabate JM. Abdominal ultrasound 
findings of disseminated tuberculosis in AIDS. J Clin Ultrasound 1997;25(1):1-6. https://doi.
org/10.1002/(sici)1097-0096(199701)25:1<1::aid-jcu1>3.0.co;2-m
45. Akinkuolie AA, Adisa AO, Agbakwuru EA, Egharevba PA, Adesunkanmi AR. Abdominal tuberculosis 
in a Nigerian teaching hospital. Afr J Med Med Sci 2008;37(3):225-229.
46. Garcia de Casasola Sanchez G, Torres Macho J, Casas Rojo JM, et al. Abdominal ultrasound and 
medical education. Rev Clin Esp 2014;214(3):131-136. https://doi.org/10.1016/j.rce.2013.09.006
47. Garcia-Casasola G, Sanchez FJ, Luordo D, et al. Basic abdominal point-of-care ultrasound training 
in the undergraduate: Students as mentors. J Ultrasound Med 2016;35(11):2483-2489. https://doi.
org/10.7863/ultra.15.11068
48. Aubry P, Reynaud JP, Nbonyingingo C, Ndabaneze E, Mucikere E. [Ultrasonographic data of the solid 
organs of the abdomen in stage IV human immunodeficiency virus infection. A prospective study of 
101 cases in central Africa]. Ann Gastroenterol Hepatol (Paris) 1994;30(2):43-52.
49. Riera M, Altes J, Homar F, et al. [Fever of unknown origin in patients with HIV infection]. Enferm 
Infecc Microbiol Clin 1996;14(10):581-585.
50. O’Keefe EA, Wood R, van Zyl A, Cariem AK. Human immunodeficiency virus-related abdominal pain 
in South Africa: Aetiology, diagnosis and survival. Scand J Gastroenterol 1998;33(2):212-217. https://
doi.org/10.1080/00365529850166978
51. Bernabeu-Wittel M, Villanueva JL, Pachón J, et al. Etiology, clinical features and outcome of splenic 
microabscesses in HIV-infected patients with prolonged fever. Eur J Clin Microbiol Infect Dis 
1999;18(5):324-329. https://doi.org/10.1007/pl00015013
52. Schinina V, Rizzi EB, Mazzuoli G, David V, Bibbolino C. US and CT findings in splenic focal lesions in 
AIDS. Acta Radiol 2000;41(6):616-620. https://doi.org/10.1080/028418500127346018
53. Barthwal MS, Rajan KE, Deoskar RB, Sharma SK. Extrapulmonary tuberculosis in human 
immunodeficiency virus infection. Med J Armed Forces India 2005;61(4):340-341. https://doi.
org/10.1016/s0377-1237(05)80059-0
54. Maniar JK, Kamath RR, Mandalia S, Shah K, Maniar A. HIV and tuberculosis: Partners in crime. 
Indian J Dermatol Venereol Leprol 2006;72(4):276-282. https://doi.org/10.4103/0378-6323.26723
55. Clarke DL, Thomson SR, Bissetty T, Madiba TE, Buccimazza I, Anderson F. A single surgical unit’s 
experience with abdominal tuberculosis in the HIV/AIDS era. World J Surg 2007;31(5):1087-1096; 
discussion 1097-1098. https://doi.org/10.1007/s00268-007-0402-8
56. Chakraborty PP, Bandyopadhyay D. Utility of abdominal ultrasonography in HIV patients. Singapore 
Med J 2009;50(7):710-714.
57. Ghiya R, Naik E, Casanas B, Izurieta R, Marfatia Y. Clinico-epidemiological profile of HIV/TB 
coinfected patients in Vadodara, Gujarat. Indian J Sex Transm Dis 2009;30(1):10-15. https://doi.
org/10.4103/0253-7184.55472
58. Bélard S, Heller T, Orie V, et al. Sonographic findings of abdominal tuberculosis in children 
with pulmonary tuberculosis. Pediatr Infect Dis J 2017;94(1):8-21. https://doi.org/10.1097/
inf.0000000000001590
59. Heller T, Mtemang’ombe EA, Huson MA, et al. Ultrasound for patients in a high HIV/tuberculosis 
prevalence setting: A needs assessment and review of focused applications for sub-Saharan Africa. Int 
J Infect Dis 2017;56:229-236. https://doi.org/10.1016/j.ijid.2016.11.001
60. Mbanjumucyo G, Henwood PC. Focused assessment with sonography for HIV-associated tuberculosis 
(FASH) case series from a Rwandan district hospital. Afr J Emerg Med 2016;6(4):198-201. https://doi.
org/10.1016/j.afjem.2016.07.001
61. Mntonintshi M, O’Mahony D, Mabunda S, Namugenyi KAF. Undiagnosed tuberculosis in patients 
with HIV infection who present with severe anaemia at a district hospital. Afr J Prim Health Care Fam 
Med 2017;9(1):e1-e6. https://doi.org/10.4102/phcfm.v9i1.1406
62. Spalgais S, Agarwal U, Sarin R, Chauhan D, Yadav A, Jaiswal A. Role of routine abdominal 
ultrasonography in intensified tuberculosis case finding algorithms at HIV clinics in high TB burden 
settings. BMC Infect Dis 2017;17:351. https://doi.org/10.1186/s12879-017-2433-6
63. Weber SF, Saravu K, Heller T, et al. Point-of-care ultrasound for extrapulmonary tuberculosis in India: 
A prospective cohort study in HIV-positive and HIV-negative presumptive tuberculosis patients. Am 
J Trop Med Hyg 2017;98(1):266-273 https://doi.org/10.4269/ajtmh.17-0486
64. Franzen SRP, Chandler C, Siribaddana S, Atashili J, Angus B, Lang T. Strategies for developing 
sustainable health research capacity in low and middle-income countries: A prospective, qualitative 
study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon 
and Sri Lanka. BMJ Open 2017;7(10):e017246. https://doi.org/10.1136/bmjopen-2017-017246
65. Shroff ZC, Javadi D, Gilson L, Kang R, Ghaffar A. Institutional capacity to generate and use evidence 
in LMICs: Current state and opportunities for HPSR. Health Res Policy Syst 2017;15:94. https://doi.
org/10.1186/s12961-017-0261-1
66. Oliver S, Bangpan M, Stansfield C, Stewart R. Capacity for conducting systematic reviews in low- 
and middle-income countries: A rapid appraisal. Health Res Policy Syst 2015;13:23. https://doi.
org/10.1186/s12961-015-0012-0
Accepted 21 January 2019.
Appendix 1. Database search terms
PubMed
(“Ultrasonography”[mesh:noexp] OR “Echocardiography”[Mesh] 
OR “Ultrasonography, Doppler”[mesh] OR “Tuberculosis/
ultrasonography”[Mesh] OR ultrasound[tiab] OR 
ultrasonograph*[tiab] OR ulrasonic[tiab] OR echocardiog*[tiab] 
OR songraph*[tiab] OR fash[tiab]) AND (“Tuberculosis”[Mesh] OR 
tuberculosis[tiab] OR tubercular[tiab])
Embase
(‘echography’/exp/mj OR ultrasound:ab,ti OR ultrasonograph*:ab,ti 
OR sonograph*:ab,ti OR ultrasonic:ab,ti OR echocardiog*:ab,ti 
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OR fash:ab,ti) AND (‘tuberculosis’/exp OR tuberculosis:ab,ti OR 
tubercular:ab,ti)
echography/exp was too sensitive and returned well over 4 000 records. 
Limited to major topic. [note carried from original notes]
Web of Science
Indexes=SCI-EXPANDED, CPCI-S Timespan=All years
TS=((ultrasound OR ultrasonograph* OR sonograph* OR ultrasonic 
OR echocardiog* OR fash) AND (tuberculosis OR tubercular))
CINAHL
(MH (“Ultrasonography” OR “Echocardiography” OR 
“Ultrasonography, Doppler”) OR TI (ultrasound OR ultrasonograph* 
OR sonograph* OR ultrasonic OR echocardiog* OR fash) OR AB 
(ultrasound OR ultrasonograph* OR sonograph* OR ultrasonic OR 
echocardiog* OR fash))
AND
((MH “Tuberculosis+”) OR TI (tuberculosis OR tubercular) OR AB 
(tuberculosis OR tubercular))
LILACS
(ultrasound OR ultrasonography OR sonography OR ultrason OR 
echocardiogaphy OR fash OR ecografia OR ultrasonografia OR 
ecocardiógrafia OR sonografia) AND (tuberculosis OR tubercular 
OR tuberculose OR tuberculeuse)
AIM
(ultrasound OR ultrasonography OR sonography OR ultrason OR 
echocardiogaphy OR fash OR ecografia OR ultrasonografia OR 
ecocardiógrafia OR sonografia) AND (tuberculosis OR tubercular 
OR tuberculose OR tuberculeuse)
